The global platelet rich plasma market size is expected to hit around USD 708.64 million by 2030 and progressing a CAGR of 11.6% over the forecast period 2022 to 2030.
The on platelet
rich plasma Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1237
Scope of the Platelet Rich Plasma Market
| Report Highlights | Details |
| Market Size | USD 708.64 Million by 2030 |
| Growth Rate | CAGR of 11.6% From 2022 to 2030 |
| Base Year | 2021 |
| Historic Data | 2017 to 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Origin, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
A recent
report provides crucial insights along with application based and forecast
information in the Global Platelet rich plasma Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Platelet rich plasma market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Platelet rich plasma
market are included as given below:
Platelet rich plasma Market Key Players
- Zimmer Biomet
- Arthrex, Inc.
- Harvest Technologies Corporation
- Stryker Corporation
- DePuy Synthes, Inc.
- Cesca Therapeutics, Inc.
- AdiStem Ltd.
- Exactech Inc.
- ISTO Biologics
- Nuo Therapeutics
Market Segments
- Leukocyte Rich PRP
- Pure PRP
- Leukocyte Rich Fibrin
By Origin
- Allogeneic PRP
- Autologous PRP
- Homologous PRP
By Application
- Cosmetic Surgery & Dermatology
- Orthopedic Surgery
- General Surgery
- Ophthalmic Surgery
- Neurosurgery
- Other
Regional Outlook
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
Report Objectives
- To define, describe, and forecast the global platelet
rich plasma market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the platelet
rich plasma market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Platelet Rich Plasma Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Platelet Rich Plasma Market
5.1. Covid-19: Platelet Rich Plasma Industry Impact
5.2. Platelet Rich Plasma Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Platelet Rich Plasma Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Platelet Rich Plasma Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Platelet Rich Plasma Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Intensifying elderly population and mounting pervasiveness of orthopedic situtaions
6.1.1.2. Growing applications of platelet-rich plasma products in hair transplant and other cosmetic applications
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
Chapter 7. Global Platelet Rich Plasma Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Platelet Rich Plasma Market Revenue by Market Players (2015-2020)
7.1.1.2. Platelet Rich Plasma Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Platelet Rich Plasma Market, By Product Type
8.1. Platelet Rich Plasma Market, by Component, 2017-2030
8.1.1. Leukocyte Rich PRP
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pure PRP
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Leukocyte Rich Fibrin
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Platelet Rich Plasma Market, By Application
9.1. Platelet Rich Plasma Market, by Application, 2017-2030
9.1.1. Allogeneic PRP
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Autologous PRP
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Homologous PRP
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Platelet Rich Plasma Market, By End-user
10.1. Platelet Rich Plasma Market, by End-user, 2017-2030
10.1.1. Cosmetic Surgery & Dermatology
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Orthopedic Surgery
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. General Surgery
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Ophthalmic Surgery
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Neurosurgery
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Platelet Rich Plasma Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2017-2030)
11.1.2. Market Revenue Forecast by Application (2017-2030)
11.1.3. Market Revenue Forecast by End-user (2017-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2017-2030)
11.2.2. Market Revenue Forecast by Application (2017-2030)
11.2.3. Market Revenue Forecast by End-user (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2017-2030)
11.3.2. Market Revenue Forecast by Application (2017-2030)
11.3.3. Market Revenue Forecast by End-user (2017-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2017-2030)
11.4.2. Market Revenue Forecast by Application (2017-2030)
11.4.3. Market Revenue Forecast by End-user (2017-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2017-2030)
11.5.2. Market Revenue Forecast by Application (2017-2030)
11.5.3. Market Revenue Forecast by End-user (2017-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017-2030)
Chapter 12. Company Profiles
12.1. Zimmer Biomet
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Arthrex, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Harvest Technologies Corporation
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Stryker Corporation
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. DePuy Synthes, Inc.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Cesca Therapeutics, Inc.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. AdiStem Ltd.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Exactech Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. ISTO Biologics
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Nuo Therapeutics
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments